Vertex makes $10B deal for commercial endocrinology biotech Crinetics Endpoints NewsVertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion WSJCRNX…
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion’s functional excipients DOWNERS…